CURAGEN CORPORATION
CuraGen Corporation is a biopharmaceutical development company that develops novel therapeutics for the treatment of cancer in the United States and Europe. Its therapeutics is based on novel targets from the human genome that play a role in proven mechanisms underlying disease. The Company's strategy continues to be focused on advancing its pipeline of pipeline of protein, antibody, and small molecule drugs in the areas of oncology, inflammatory diseases, and diabetes, promising therapeutics through clinical and preclinical development. CuraGen Corporation was founded in 1991 and is headquartered in Branford, Connecticut. As of October 1, 2009, CuraGen Corporation operates as a subsidiary of Celldex Therapeutics, Inc.
CURAGEN CORPORATION
Industry:
Biopharma Biotechnology Genetics Health Care Therapeutics
Founded:
1991-01-01
Address:
Needham, Massachusetts, United States
Country:
United States
Total Employee:
101+
Status:
Active
Similar Organizations
Leptos Biomedical
Leptos Biomedical offers a proprietary neuromodulation therapy solution for chronic obesity.
Current Employees Featured
Founder
Stock Details
More informations about "Curagen Corporation"
CuraGen Company Profile | Management and Employees List
CuraGen Profile and History. CuraGen Corporation (Nasdaq: CRGN) is a biopharmaceutical company developing diverse approaches, including novel protein, antibody, and small …See details»
Curagen Company Profile 2024: Valuation, Investors, Acquisition
Curagen General Information Description. Developer of novel therapeutics designed to treat cancer. The company's therapeutics focuses on the development of CR011-vcMMAE, a …See details»
CuraGen Corporation Company Profile - Dun & Bradstreet
CuraGen Corporation. Get a D&B Hoovers Free Trial. Overview Company Description: In the war against cancer, CuraGen is looking for the ultimate weapon. The drug company's main focus …See details»
Curagen Corporation - Funding, Financials, Valuation & Investors
Mar 18, 1998 Curagen Corporation is registered under the ticker NASDAQ:CRGN . Their stock opened with $12.00 in its Mar 18, 1998 IPO. Stock Symbol NASDAQ:CRGN ; Money Raised …See details»
Curagen Corporation
Nov 21, 2024 Curagen Corporation is a research-based biotechnology company dedicated to discovering and developing novel therapeutics in the life sciences industry. We are committed …See details»
Company CuraGen Corporation - MarketScreener.com
Company CuraGen Corporation. Best financial portal +951% of historical performance More than 20 years at your side + 1,000,000 members Quick & easy cancellation Our Experts are here …See details»
CuraGen - Overview, News & Similar companies | ZoomInfo.com
CuraGen Corporation (Nasdaq: CRGN) is a biopharmaceutical company developing diverse approaches, including novel protein, antibody, and small molec ule therapeutics, that aim to …See details»
Curagen Corporation - Contacts, Employees, Board Members
Organization. Curagen Corporation . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. About. …See details»
CuraGen - Company Profile - Tracxn
Nov 7, 2024 CuraGen ranks 12th among 33 active competitors. 3 of its competitors are funded while 4 have exited. Overall, CuraGen and its competitors have raised over $8.29M in funding …See details»
CURAGEN CORP (Form: 10-K/A, Filing Date: 06/19/2009)
CURAGEN CORPORATION (Exact name of registrant as specified in its charter) Delaware 06-1331400 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer …See details»
Curagen Corporation (crgn) - The Wall Street Transcript
Apr 9, 2001 dr. JONATHAN M. ROTHBERG is the Founder, Chairman, President and Chief Executive Officer of CuraGen Corporation, a genomics-based pharmaceutical company …See details»
Celldex Therapeutics, Inc. to Buy CuraGen Corporation in $94
May 29, 2009 The deal also offers CuraGen investors reduced risk via ownership of a broader portfolio, while still retaining upside potential of CR011 in the combined company.” CuraGen …See details»
CuraGen Corporation - PubMed
1 CuraGen Corporation, 555 Long Wharf Drive, New Haven, CT 06511, USA. PMID: 12164777 DOI: 10.1517/14622416.3.4.551 Abstract CuraGen Scientists have developed a deep …See details»
Curagen Corporation - Tech Stack, Apps, Patents & Trademarks
Organization. Curagen Corporation . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 8. ... Curagen …See details»
CuraGen Corporation Careers and Employment | Indeed.com
Aug 18, 2015 Find out what works well at CuraGen Corporation from the people who know best. Get the inside scoop on jobs, salaries, top office locations, and CEO insights. Compare pay for …See details»
Working at CuraGen Corporation: 2 Reviews - Indeed
Reviews from CuraGen Corporation employees about CuraGen Corporation culture, salaries, benefits, work-life balance, management, job security, and more.See details»
Curagen Corporation Alumni Founded Companies - Crunchbase
Nov 4, 2009 CuraGen Corporation, a biopharmaceutical development company, develops novel therapeutics for the treatment of cancer. This list of organizations founded by former …See details»
CuraGen Corporation - The New York Times
TECHNOLOGY; Bayer and CuraGen in $1.5 Billion Pact to Develop Drugs. Bayer AG and CuraGen Corp will spend as much as $1.5 billion to use CuraGen's gene-hunting technology …See details»